Inhibitory effect of rosiglitazone on the acid-induced intracellular generation of hydrogen peroxide in cultured feline esophageal epithelial cells

Naunyn-Schmiedeberg's Archives of Pharmacology

Volumn 383, Issue 2, 2011, Pages 191-201

  Park, Sun Young ^a   Sohn, Uy Dong ^a  

^a Chung Ang University   (South Korea)

Author keywords

Catalase; Esophageal epithelial cell; Hydrogen peroxide; NADPH oxidase; Peroxisome proliferator activated receptor; Rosiglitazone

Indexed keywords

2 CHLORO 5 NITROBENZANILIDE; 3 (4,5 DIMETHYL 2 THIAZOLYL) 2,5 DIPHENYLTETRAZOLIUM BROMIDE; ACETYLCYSTEINE; CATALASE; COPPER ZINC SUPEROXIDE DISMUTASE; DIPHENYLIODONIUM SALT; HYDROGEN PEROXIDE; MANGANESE SUPEROXIDE DISMUTASE; MESSENGER RNA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; REACTIVE OXYGEN METABOLITE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; ROSIGLITAZONE; SUPEROXIDE DISMUTASE;

ANIMAL CELL; ANIMAL CELL CULTURE; ANIMAL TISSUE; ANTIOXIDANT ACTIVITY; ARTICLE; CAT; CELL ISOLATION; CELL VIABILITY; CONTROLLED STUDY; DRUG EFFECT; DUODENOGASTRIC REFLUX; ENZYME ACTIVITY; EPITHELIUM CELL; ESOPHAGEAL EPITHELIAL CELL; ESOPHAGUS; FEMALE; IMMUNOCYTOCHEMISTRY; MALE; NONHUMAN; PH; PROTEIN EXPRESSION; WESTERN BLOTTING;

ANILIDES; ANIMALS; ANTIOXIDANTS; BLOTTING, WESTERN; CATALASE; CATS; CELL CULTURE TECHNIQUES; CELL SURVIVAL; CELLS, CULTURED; CULTURE MEDIA; EPITHELIAL CELLS; ESOPHAGUS; FEMALE; HYDROCHLORIC ACID; HYDROGEN PEROXIDE; HYDROGEN-ION CONCENTRATION; MALE; NADP; PPAR GAMMA; SUPEROXIDE DISMUTASE; THIAZOLIDINEDIONES;

EID: 79954427149     PISSN: 00281298     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00210-010-0594-6     Document Type: Article

References (68)

1. Aljada A, Garg R, Ghanim H, Mohanty P, Hamouda W, Assian E, Dandona P (2001) Nuclear factor-kappaB suppressive and inhibitor-kappaB stimulatory effects of troglitazone in obese patients with type 2 diabetes: evidence of an antiinflammatory action? J Clin Endocrinol Metab 86:3250-3256 (Pubitemid 32674119)
2. Al-Taie OH, Graf T, Illert B, Katzenberger T, Mork H, Kraus MR, Barthelmes HU, Scheurlen M, Seufert J (2009) Differential effects of PPARgamma activation by the oral antidiabetic agent pioglitazone in Barrett's carcinoma in vitro and in vivo. J Gastroenterol 44:919-929
3. Bagi Z, Koller A, Kaley G (2004) PPARgamma activation, by reducing oxidative stress, increases NO bioavailability in coronary arterioles of mice with type 2 diabetes. Am J Physiol Heart Circ Physiol 286: H742-H748 (Pubitemid 38140357)
4. Beckstead BL, Pan S, Bhrany AD, Bratt-Leal AM, Ratner BD, Giachelli CM (2005) Esophageal epithelial cell interaction with synthetic and natural scaffolds for tissue engineering. Biomaterials 26:6217-6228 (Pubitemid 40826990)
5. Bernardo A, Bianchi D, Magnaghi V, Minghetti L (2009) Peroxisome proliferator-activated receptor-gamma agonists promote differentiation and antioxidant defenses of oligodendrocyte progenitor cells. J Neuropathol Exp Neurol 68:797-808
6. Bishop-Bailey D (2000) Peroxisome proliferator-activated receptors in the cardiovascular system. Br J Pharmacol 129:823-834
7. Brockman JA, Gupta RA, Dubois RN (1998) Activation of PPARgamma leads to inhibition of anchorage-independent growth of human colorectal cancer cells. Gastroenterology 115:1049-1055 (Pubitemid 28485592)
8. Ceolotto G, Gallo A, Papparella I, Franco L, Murphy E, Iori E, Pagnin E, Fadini GP, Albiero M, Semplicini A, Avogaro A (2007) Rosiglitazone reduces glucose-induced oxidative stress mediated by NAD (P) H oxidase via AMPK-dependent mechanism. Arterioscler Thromb Vasc Biol 27:2627-2633 (Pubitemid 350158915)
9. Chinetti G, Fruchart JC, Staels B (2003) Peroxisome proliferatoractivated receptors and inflammation: from basic science to clinical applications. Int J Obes Relat Metab Disord 27 (Suppl 3): S41-S45 (Pubitemid 38019187)
10. Cuzzocrea S, Ianaro A, Wayman NS, Mazzon E, Pisano B, Dugo L, Serraino I, Di Paola R, Chatterjee PK, Di Rosa M, Caputi AP, Thiemermann C (2003) The cyclopentenone prostaglandin 15-deoxy-delta (12, 14) - PGJ2 attenuates the development of colon injury caused by dinitrobenzene sulphonic acid in the rat. Br J Pharmacol 138:678-688 (Pubitemid 36315316)
11. Dubuquoy L, Jansson EA, Deeb S, Rakotobe S, Karoui M, Colombel JF, Auwerx J, Pettersson S, Desreumaux P (2003) Impaired expression of peroxisome proliferator-activated receptor gamma in ulcerative colitis. Gastroenterology 124:1265-1276 (Pubitemid 36531802)
12. Dvorak K, Fass R, Dekel R, Payne CM, Chavarria M, Dvorakova B, Bernstein H, Bernstein C, Garewal H (2006) Esophageal acid exposure at pH < or = 2 is more common in Barrett's esophagus patients and is associated with oxidative stress. Dis Esophagus 19:366-372 (Pubitemid 44390443)
13. Fajas L, Auboeuf D, Raspe E, Schoonjans K, Lefebvre AM, Saladin R, Najib J, Laville M, Fruchart JC, Deeb S, Vidal-Puig A, Flier J, Briggs MR, Staels B, Vidal H, Auwerx J (1997) The organization, promoter analysis, and expression of the human PPAR-gamma gene. J Biol Chem 272:18779-18789 (Pubitemid 27318225)
14. Fantone JC, Ward PA (1982) Role of oxygen-derived free radicals and metabolites in leukocyte-dependent inflammatory reactions. Am J Pathol 107:395-418
15. Feagins LA, Zhang HY, Zhang X, Hormi-Carver K, Thomas T, Terada LS, Spechler SJ, Souza RF (2008) Mechanisms of oxidant production in esophageal squamous cell and Barrett's cell lines. Am J Physiol Gastrointest Liver Physiol 294: G411-G417 (Pubitemid 351253330)
16. Ferguson HE, Thatcher TH, Olsen KC, Garcia-Bates TM, Baglole CJ, Kottmann RM, Strong ER, Phipps RP, Sime PJ (2009) Peroxisome proliferator-activated receptor-gamma ligands induce heme oxygenase-1 in lung fibroblasts by a PPARgammaindependent, glutathione-dependent mechanism. Am J Physiol Lung Cell Mol Physiol 297: L912-L919
17. Genestra M (2007) Oxyl radicals, redox-sensitive signalling cascades and antioxidants. Cell Signal 19:1807-1819 (Pubitemid 47090178)
18. Ghanim H, Garg R, Aljada A, Mohanty P, Kumbkarni Y, Assian E, Hamouda W, Dandona P (2001) Suppression of nuclear factorkappaB and stimulation of inhibitor kappaB by troglitazone: evidence for an anti-inflammatory effect and a potential antiatherosclerotic effect in the obese. J Clin Endocrinol Metab 86:1306-1312 (Pubitemid 32323021)
19. Giri S, Rattan R, Singh AK, Singh I (2004) The 15-deoxy-delta12, 14-prostaglandin J2 inhibits the inflammatory response in primary rat astrocytes via down-regulating multiple steps in phosphatidylinositol 3-kinase-Akt-NF- kappaB-p300 pathway independent of peroxisome proliferator-activated receptor gamma. J Immunol 173:5196-5208 (Pubitemid 39387803)
20. Girnun GD, Domann FE, Moore SA, Robbins ME (2002) Identification of a functional peroxisome proliferator-activated receptor response element in the rat catalase promoter. Mol Endocrinol 16:2793-2801 (Pubitemid 36020658)
21. Grommes C, Landreth GE, Heneka MT (2004) Antineoplastic effects of peroxisome proliferator-activated receptor gamma agonists. Lancet Oncol 5:419-429 (Pubitemid 38878045)
22. Gumieniczek A (2003) Effect of the new thiazolidinedionepioglitazone on the development of oxidative stress in liver and kidney of diabetic rabbits. Life Sci 74:553-562 (Pubitemid 37419966)
23. Gumieniczek A (2005) Effect of pioglitazone on hyperglycemiainduced alterations in antioxidative system in tissues of alloxantreated diabetic animals. Exp Toxicol Pathol 56:321-326 (Pubitemid 40312757)
24. Gupta RA, Sarraf P, Brockman JA, Shappell SB, Raftery LA, Willson TM, DuBois RN (2003) Peroxisome proliferator-activated receptor gamma and transforming growth factor-beta pathways inhibit intestinal epithelial cell growth by regulating levels of TSC-22. J Biol Chem 278:7431-7438 (Pubitemid 36800748)
25. Han C, Demetris AJ, Michalopoulos GK, Zhan Q, Shelhamer JH, Wu T (2003) PPARgamma ligands inhibit cholangiocarcinoma cell growth through p53-dependent GADD45 and p21 pathway. Hepatology 38:167-177 (Pubitemid 36775808)
26. Harmon JW, Johnson LF, Maydonovitch CL (1981) Effects of acid and bile salts on the rabbit esophageal mucosa. Dig Dis Sci 26:65-72 (Pubitemid 11217688)
27. Huin C, Corriveau L, Bianchi A, Keller JM, Collet P, Kremarik-Bouillaud P, Domenjoud L, Becuwe P, Schohn H, Menard D, Dauca M (2000) Differential expression of peroxisome proliferator-activated receptors (PPARs) in the developing human fetal digestive tract. J Histochem Cytochem 48:603-611 (Pubitemid 30233184)
28. Hunt RH (1999) Importance of pH control in the management of GERD. Arch Intern Med 159:649-657 (Pubitemid 29177653)
29. Jung TW, Lee JY, Shim WS, Kang ES, Kim SK, Ahn CW, Lee HC, Cha BS (2007) Rosiglitazone protects human neuroblastoma SH-SY5Y cells against MPP+ induced cytotoxicity via inhibition of mitochondrial dysfunction and ROS production. J Neurol Sci 253:53-60 (Pubitemid 46185454)
30. Kanda Y, Shimoda M, Hamamoto S, Tawaramoto K, Kawasaki F, Hashiramoto M, Nakashima K, Matsuki M, Kaku K (2010) Molecular mechanism by which pioglitazone preserves pancreatic beta-cells in obese diabetic mice: evidence for acute and chronic actions as a PPARgamma agonist. Am J Physiol Endocrinol Metab 298: E278-E286
31. Katayama K, Wada K, Nakajima A, Mizuguchi H, Hayakawa T, Nakagawa S, Kadowaki T, Nagai R, Kamisaki Y, Blumberg RS, Mayumi T (2003) A novel PPAR gamma gene therapy to control inflammation associated with inflammatory bowel disease in a murine model. Gastroenterology 124:1315-1324 (Pubitemid 36531806)
32. Kilter H, Werner M, Roggia C, Reil JC, Schafers HJ, Kintscher U, Bohm M (2009) The PPAR-gamma agonist rosiglitazone facilitates Akt rephosphorylation and inhibits apoptosis in cardiomyocytes during hypoxia/reoxygenation. Diab Obes Metab 11:1060-1067
33. Kivilaakso E, Fromm D, Silen W (1980) Effect of bile salts and related compounds on isolated esophageal mucosa. Surgery 87:280-285 (Pubitemid 10176052)
34. Koga H, Sakisaka S, Harada M, Takagi T, Hanada S, Taniguchi E, Kawaguchi T, Sasatomi K, Kimura R, Hashimoto O, Ueno T, Yano H, Kojiro M, Sata M (2001) Involvement of p21 (WAF1/Cip1), p27 (Kip1), and p18 (INK4c) in troglitazone-induced cell-cycle arrest in human hepatoma cell lines. Hepatology 33:1087-1097 (Pubitemid 32378207)
35. Kojima K, Shimada T, Mitobe Y, Yoshiura K, Hiraishi H, Terano A (2002) Effect of PPARgamma ligands on the viability of gastric epithelial cells. Aliment Pharmacol Ther 16 (Suppl 2):67-73 (Pubitemid 41771464)
36. Lefebvre M, Paulweber B, Fajas L, Woods J, McCrary C, Colombel JF, Najib J, Fruchart JC, Datz C, Vidal H, Desreumaux P, Auwerx J (1999) Peroxisome proliferator-activated receptor gamma is induced during differentiation of colon epithelium cells. J Endocrinol 162:331-340 (Pubitemid 29447426)
37. Lin MS, Chen WC, Bai X, Wang YD (2007) Activation of peroxisome proliferator-activated receptor gamma inhibits cell growth via apoptosis and arrest of the cell cycle in human colorectal cancer. J Dig Dis 8:82-88 (Pubitemid 46773619)
38. Motomura W, Okumura T, Takahashi N, Obara T, Kohgo Y (2000) Activation of peroxisome proliferator-activated receptor gamma by troglitazone inhibits cell growth through the increase of p27KiP1 in human. Pancreatic carcinoma cells. Cancer Res 60:5558-5564
39. Mueller E, Sarraf P, Tontonoz P, Evans RM, Martin KJ, Zhang M, Fletcher C, Singer S, Spiegelman BM (1998) Terminal differentiation of human breast cancer through PPAR gamma. Mol Cell 1:465-470 (Pubitemid 128378895)
40. Mughal RS, Warburton P, O'Regan DJ, Ball SG, Turner NA, Porter KE (2009) Peroxisome proliferator-activated receptor gammaindependent effects of thiazolidinediones on human cardiac myofibroblast function. Clin Exp Pharmacol Physiol 36:478-486
41. Mukherjee R, Jow L, Croston GE, Paterniti JR Jr (1997) Identification, characterization, and tissue distribution of human peroxisome proliferator-activated receptor (PPAR) isoforms PPARgamma2 versus PPARgamma1 and activation with retinoid X receptor agonists and antagonists. J Biol Chem 272:8071-8076 (Pubitemid 27137374)
42. Nakajima A, Wada K, Miki H, Kubota N, Nakajima N, Terauchi Y, Ohnishi S, Saubermann LJ, Kadowaki T, Blumberg RS, Nagai R, Matsuhashi N (2001) Endogenous PPAR gamma mediates antiinflammatory activity in murine ischemia-reperfusion injury. Gastroenterology 120:460-469 (Pubitemid 32147643)
43. Oh TY, Lee JS, Ahn BO, Cho H, Kim WB, Kim YB, Surh YJ, Cho SW, Hahm KB (2001) Oxidative damages are critical in pathogenesis of reflux esophagitis: implication of antioxidants in its treatment. Free Radic Biol Med 30:905-915 (Pubitemid 32289268)
44. Ouatu-Lascar R, Fitzgerald RC, Triadafilopoulos G (1999) Differentiation and proliferation in Barrett's esophagus and the effects of acid suppression. Gastroenterology 117:327-335 (Pubitemid 29352940)
45. Parks DA, Bulkley GB, Granger DN (1983) Role of oxygen-derived free radicals in digestive tract diseases. Surgery 94:415-422 (Pubitemid 13007943)
46. Patel KM, Wright KL, Whittaker P, Chakravarty P, Watson ML, Ward SG (2005) Differential modulation of COX-2 expression in A549 airway epithelial cells by structurally distinct PPAR (gamma) agonists: evidence for disparate functional effects which are independent of NF-(kappa) B and PPAR (gamma). Cell Signal 17:1098-1110 (Pubitemid 40933530)
47. Pedersen G, Brynskov J (2010) Topical rosiglitazone treatment improves ulcerative colitis by restoring peroxisome proliferatorsactivated receptor-gamma activity. Am J Gastroenterol 105:1595-1603
48. Rageul J, Mottier S, Jarry A, Shah Y, Théoleyre S, Masson D, Gonzalez FJ, Laboisse CL, Denis MG (2009) KLF4-dependent, PPARgamma-induced expression of GPA33 in colon cancer cell lines. Int J Cancer 125:2802-2809
49. Richter JE, Bradley LA, DeMeester TR, Wu WC (1992) Normal 24-hr ambulatory esophageal pH values. Influence of study center, pH electrode, age, and gender. Dig Dis Sci 37:849-856
50. Rosen ED, Sarraf P, Troy AE, Bradwin G, Moore K, Milstone DS, Spiegelman BM, Mortensen RM (1999) PPAR gamma is required for the differentiation of adipose tissue in vivo and in vitro. Mol Cell 4:611-617 (Pubitemid 29531140)
51. Rousseaux C, Lefebvre B, Dubuquoy L, Lefebvre P, Romano O, Auwerx J, Metzger D, Wahli W, Desvergne B, Naccari GC, Chavatte P, Farce A, Bulois P, Cortot A, Colombel JF, Desreumaux P (2005) Intestinal antiinflammatory effect of 5-aminosalicylic acid is dependent on peroxisome proliferatoractivated receptor-gamma. J Exp Med 201:1205-1215 (Pubitemid 40629065)
52. Sanchez-Hidalgo M, Martin AR, Villegas I, Alarcon De La Lastra C (2005) Rosiglitazone, an agonist of peroxisome proliferatorsactivated receptor gamma, reduces chronic colonic inflammation in rats. Biochem Pharmacol 69:1733-1744 (Pubitemid 40780073)
53. Sasaki H, Tanahashi M, Yukiue H, Moiriyama S, Kobayashi Y, Nakashima Y, Kaji M, Kiriyama M, Fukai I, Yamakawa Y, Fujii Y (2002) Decreased peroxisome proliferator-activated receptor gamma gene expression was correlated with poor prognosis in patients with lung cancer. Lung Cancer 36:71-76 (Pubitemid 34224898)
54. Scoditti E, Massaro M, Carluccio MA, Distante A, Storelli C, De Caterina R (2010) PPARgamma agonists inhibit angiogenesis by suppressing PKCalpha-and CREB-mediated COX-2 expression in the human endothelium. Cardiovasc Res 86:302-310
55. Song HJ, Shin CY, Oh TY, Min YS, Park ES, Sohn UD (2009) Eupatilin with heme oxygenase-1-inducing ability protects cultured feline esophageal epithelial cells from cell damage caused by indomethacin. Biol Pharm Bull 32:589-596
56. Sorrentino SA, Bahlmann FH, Besler C, Muller M, Schulz S, Kirchhoff N, Doerries C, Horvath T, Limbourg A, Limbourg F, Fliser D, Haller H, Drexler H, Landmesser U (2007) Oxidant stress impairs in vivo reendothelialization capacity of endothelial progenitor cells from patients with type 2 diabetes mellitus: restoration by the peroxisome proliferator-activated receptorgamma agonist rosiglitazone. Circulation 116:163-173 (Pubitemid 47057522)
57. Su CG, Wen X, Bailey ST, Jiang W, Rangwala SM, Keilbaugh SA, Flanigan A, Murthy S, Lazar MA, Wu GD (1999) A novel therapy for colitis utilizing PPAR-gmma ligands to inhibit the epithelial inflammatory response. J Clin Invest 104:383-389 (Pubitemid 29534322)
58. Takagi T, Naito Y, Tomatsuri N, Handa O, Ichikawa H, Yoshida N, Yoshikawa T (2002) Pioglitazone, a PPAR-gamma ligand, provides protection from dextran sulfate sodium-induced colitis in mice in association with inhibition of the NF-kappaB-cytokine cascade. Redox Rep 7:283-289 (Pubitemid 36032915)
59. Tan X, Dagher H, Hutton CA, Bourke JE (2010) Effects of PPAR gamma ligands on TGF-beta1-induced epithelial-mesenchymal transition in alveolar epithelial cells. Respir Res 11:21
60. Terashita Y, Sasaki H, Haruki N, Nishiwaki T, Ishiguro H, Shibata Y, Kudo J, Konishi S, Kato J, Koyama H, Kimura M, Sato A, Shinoda N, Kuwabara Y, Fujii Y (2002) Decreased peroxisome proliferator-activated receptor gamma gene expression is correlated with poor prognosis in patients with esophageal cancer. Jpn J Clin Oncol 32:238-243 (Pubitemid 43102806)
61. Thompson EA (2007) PPARgamma physiology and pathology in gastrointestinal epithelial cells. Mol Cells 24:167-176 (Pubitemid 350177175)
62. Tobey NA, Hosseini SS, Caymaz-Bor C, Wyatt HR, Orlando GS, Orlando RC (2001) The role of pepsin in acid injury to esophageal epithelium. Am J Gastroenterol 96:3062-3070 (Pubitemid 33095343)
63. Weiss SJ (1989) Tissue destruction by neutrophils. N Engl J Med 320:365-376 (Pubitemid 19106873)
64. Wetscher GJ, Hinder RA, Bagchi D, Hinder PR, Bagchi M, Perdikis G, McGinn T (1995a) Reflux esophagitis in humans is mediated by oxygen-derived free radicals. Am J Surg 170:552-556, discussion 556-557
65. Wetscher GJ, Perdikis G, Kretchmar DH, Stinson RG, Bagchi D, Redmond EJ, Adrian TE, Hinder RA (1995b) Esophagitis in Sprague-Dawley rats is mediated by free radicals. Dig Dis Sci 40:1297-1305
66. Wu J, Lei MX, Xie XY, Liu L, She YM, Mo J, Wang S (2009) Rosiglitazone inhibits high glucose-induced apoptosis in human umbilical vein endothelial cells through the PI3K/Akt/eNOS pathway. Can J Physiol Pharmacol 87:549-555
67. Yi JH, Park SW, Brooks N, Lang BT, Vemuganti R (2008) PPARgamma agonist rosiglitazone is neuroprotective after traumatic brain injury via anti-inflammatory and anti-oxidative mechanisms. Brain Res 1244:164-172
68. Zhang A, Jia Z, Guo X, Yang T (2007) Aldosterone induces epithelialmesenchymal transition via ROS of mitochondrial origin. Am J Physiol Ren Physiol 293(3):F723-F731 (Pubitemid 47403342)